Blood clots tied to vaccines can also occur spontaneously, scientists find
The discovery has shed light on a complex blood interaction that has likely always been present in humans but was unnoticed ...
Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
cambridgeindependent1d
AstraZeneca revenues rise to $54bn as it enters ‘unprecedented’ period for company
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
The Independent6d
Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca have not stated plans for an alternative. An FT report meanwhile said that vaccines were “off strategy” for AstraZeneca, suggesting “figures on both sides of the negotiations hav ...
IFLScience on MSN3d
Montana Considers Becoming First US State To Ban mRNA Vaccine Use
O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...
Cutting edge Oxford malaria vaccine trial in jeopardy as USAID payments frozen
The Oxford Vaccine Group, led by Prof Andrew Pollard, is renowned for collaborating with Oxford’s Jenner Institute in ...
EurekAlert!1d
Cracking the code of lethal antibodies in a new blood-clotting disorder
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...
Pliant Therapeutics: Strange Volatility
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
Coroner steps down from vaccine death case amid claims of bias
A coroner overseeing the inquest of a woman who died following a Covid vaccine has stood down amid claims of bias and ...
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
AIM ImmunoTech advances Ampligen for avian influenza vaccine
Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...